267 related articles for article (PubMed ID: 32397263)
21. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
22. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.
Novak B; Heesen L; Schary N; Lübbert H
Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796
[TBL] [Abstract][Full Text] [Related]
23. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
24. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
25. Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
Osman-Ponchet H; Sevin K; Gaborit A; Kouidhi M; Hanaizi J; Comby P; Ruty B; Bouvier G
Photodiagnosis Photodyn Ther; 2017 Mar; 17():75-81. PubMed ID: 27903435
[TBL] [Abstract][Full Text] [Related]
26. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
27. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
28. A Formulation Study of 5-Aminolevulinic Encapsulated in DPPC Liposomes in Melanoma Treatment.
Lin MW; Huang YB; Chen CL; Wu PC; Chou CY; Wu PC; Hung SY
Int J Med Sci; 2016; 13(7):483-9. PubMed ID: 27429584
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.
Anand S; Wilson C; Hasan T; Maytin EV
Cancer Res; 2011 Sep; 71(18):6040-50. PubMed ID: 21807844
[TBL] [Abstract][Full Text] [Related]
30. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Tyrrell JS; Morton C; Campbell SM; Curnow A
Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
[TBL] [Abstract][Full Text] [Related]
31. Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial.
Choi SH; Kim KH; Song KH
JAMA Dermatol; 2017 Mar; 153(3):289-295. PubMed ID: 28199463
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin IX.
Gilaberte Y; Pereboom D; Carapeto FJ; Alda JO
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):43-9. PubMed ID: 9361128
[TBL] [Abstract][Full Text] [Related]
33. Resistance of oral cancer cells to 5-ALA-mediated photodynamic therapy.
Rosin FCP; Teixeira MG; Pelissari C; Corrêa L
J Cell Biochem; 2018 Apr; 119(4):3554-3562. PubMed ID: 29227548
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
Pye A; Campbell S; Curnow A
J Cancer Res Clin Oncol; 2008 Aug; 134(8):841-9. PubMed ID: 18239941
[TBL] [Abstract][Full Text] [Related]
35. MAL-associated methyl nicotinate for topical PDT improvement.
Stringasci MD; Ciol H; Romano RA; Buzza HH; Leite IS; Inada NM; Bagnato VS
J Photochem Photobiol B; 2020 Dec; 213():112071. PubMed ID: 33242779
[TBL] [Abstract][Full Text] [Related]
36. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
Heerfordt IM; Bieliauskiene G; Wulf HC
Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
[TBL] [Abstract][Full Text] [Related]
37. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
[TBL] [Abstract][Full Text] [Related]
38. Mitotic Catastrophe Induced in HeLa Tumor Cells by Photodynamic Therapy with Methyl-aminolevulinate.
Mascaraque M; Delgado-Wicke P; Damian A; Lucena SR; Carrasco E; Juarranz Á
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862116
[TBL] [Abstract][Full Text] [Related]
39. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
40. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
Tyrrell J; Campbell S; Curnow A
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):86-97. PubMed ID: 20510303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
